Literature DB >> 15104278

Cytogenetic alterations in chagasic achalasia compared to esophageal carcinoma.

Fernanda da Silva Manoel-Caetano1, Aldenis Albaneze Borim, Alaor Caetano, Patrícia Maluf Cury, Ana Elizabete Silva.   

Abstract

Patients with chagasic achalasia (megaesophagus) are liable to have an additional 1.7-20% possibility of developing esophageal squamous cell carcinoma (ESCC). We applied a fluorescence in situ hybridization technique in 20 such patients and found aneuploidies of chromosomes 7, 11, and 17 in 60% (12 of 20 specimens) and deletion of the TP53 gene in 54.5% (6 of 11 specimens; it was only possible to obtain data by FISH technique from 11 of the 20 achalasia patients). The main aneuploidies detected were chromosome 7 monosomy or trisomy (35%) in mid-third megaesophagus cases, and chromosome 17 monosomy or trisomy (25%) in distal-third cases. TP53 gene deletion was more frequent in mid-third (62.5%) than in distal-third megaesophagus cases (40%). In chagasic megaesophagus, no amplification of the cyclin D1 gene (CCND1) was observed. Comparing chagasic megaesophagus to ESCC, we found a higher frequency of aneuploidies in all 10 tumors. The main alterations were trisomy or tetrasomy of chromosomes 17 (90%), 11 (70%), and 7 (70%). Amplification of CCND1 was evidenced as a cluster in 70% of the tumors (22-99% of nuclei), while TP53 gene deletion occurred in 100%. To our knowledge, this is the first cytogenetic analysis of chagasic megaesophagus to show that aneuploidies of chromosomes 7, 11, and 17, and TP53 gene deletion might be related to increased risk for malignancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104278     DOI: 10.1016/s0165-4608(03)00274-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

2.  Chromosome 11 aneusomy in esophageal cancers and precancerous lesions--an early event in neoplastic transformation: an interphase fluorescence in situ hybridization study from south India.

Authors:  Vasavi Mohan; Shivani Ponnala; Hemakumar M Reddy; Radha Sistla; Rachel A Jesudasan; Yog Raj Ahuja; Qurratulain Hasan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  Chromosomal imbalances are uncommon in chagasic megaesophagus.

Authors:  Marilanda F Bellini; Antonio J Manzato; Ana E Silva; Marileila Varella-Garcia
Journal:  BMC Gastroenterol       Date:  2010-02-17       Impact factor: 3.067

4.  Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression.

Authors:  Lucimari Bizari; Eloiza Helena Tajara; Ana Elizabete Silva
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

5.  Biologic and genetics aspects of chagas disease at endemic areas.

Authors:  Marilanda Ferreira Bellini; Rosana Silistino-Souza; Marileila Varella-Garcia; Maria Tercília Vilela de Azeredo-Oliveira; Ana Elizabete Silva
Journal:  J Trop Med       Date:  2012-03-08

Review 6.  Achalasia and esophageal cancer: risks and links.

Authors:  Maura Torres-Aguilera; José María Remes Troche
Journal:  Clin Exp Gastroenterol       Date:  2018-09-06

7.  Parasite-microbe-host interactions and cancer risk.

Authors:  Nolwenn M Dheilly; Paul W Ewald; Paul J Brindley; Raina N Fichorova; Frédéric Thomas
Journal:  PLoS Pathog       Date:  2019-08-15       Impact factor: 6.823

Review 8.  The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders.

Authors:  Francisco Tustumi; Jorge Henrique Bento de Sousa; Nicolas Medeiros Dornelas; Guilherme Maganha Rosa; Milton Steinman; Edno Tales Bianchi
Journal:  Med Sci (Basel)       Date:  2021-05-21

Review 9.  Parasite Infection, Carcinogenesis and Human Malignancy.

Authors:  Hoang van Tong; Paul J Brindley; Christian G Meyer; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-12-02       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.